Literature DB >> 8427386

Active surveillance and risk factors for leptospirosis in Hawaii.

D M Sasaki1, L Pang, H P Minette, C K Wakida, W J Fujimoto, S J Manea, R Kunioka, C R Middleton.   

Abstract

A clinic-hospital-based leptospirosis surveillance program was conducted to determine the morbidity and risk factors in nonepidemic settings. The study was conducted on two islands, Kauai and Hawaii (Big Island), in the state of Hawaii for one year during 1988 and 1989. An active, more comprehensive case detection system was used on the Big Island that enabled us to determine the incidence of clinical disease. Subjects from both islands were used to conduct a case-control study for risk factors. One hundred seventy-two subjects from the Big Island (who presented with any two of the following symptoms: fever, headache, myalgia, or nausea/vomiting) were enrolled in the study. Twenty cases were diagnosed by culture, serology, or fluorescent antibody tissue staining at autopsy. Six cases required hospitalization and two succumbed to fatal infections. We estimated that these cases represented an annual incidence rate of 128 per 100,000 person-years in our target population. For 33 cases, 77 controls were matched for island, age, sex, and time of onset of illness. Interviews were conducted retrospectively in a double-blinded fashion with cases and controls and evaluated approximately 30 risk factors. Factors that were associated most strongly with development of leptospirosis were household use of rainwater catchment systems (P = 0.003), presence of skin cuts during the incubation period (P = 0.008), contact with cattle or the urine of cattle (P = 0.05 and P = 0.03, respectively), and handling of animal tissues (P = 0.005).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8427386     DOI: 10.4269/ajtmh.1993.48.35

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  22 in total

1.  Lemierre's syndrome mimicking leptospirosis.

Authors:  Dagmar Lin; Nuntra Suwantarat; Royden S Young
Journal:  Hawaii Med J       Date:  2010-07

2.  Prospective serological study of leptospirosis in southern Spain.

Authors:  C Dastis-Bendala; E de Villar-Conde; I Marin-Leon; L Manzanares-Torne; M J Perez-Lozano; G Cano-Fuentes; J Vargas-Romero; T Pumarola-Suñe
Journal:  Eur J Epidemiol       Date:  1996-06       Impact factor: 8.082

3.  Rat-bite leptospirosis.

Authors:  J H Gollop; A R Katz; R C Rudoy; D M Sasaki
Journal:  West J Med       Date:  1993-07

Review 4.  A global research agenda for leptospirosis.

Authors:  E R Cachay; J M Vinetz
Journal:  J Postgrad Med       Date:  2005 Jul-Sep       Impact factor: 1.476

5.  Evaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosis.

Authors:  B Flannery; D Costa; F P Carvalho; H Guerreiro; J Matsunaga; E D Da Silva; A G Ferreira; L W Riley; M G Reis; D A Haake; A I Ko
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

6.  Evaluation of eight rapid screening tests for acute leptospirosis in Hawaii.

Authors:  Paul V Effler; April K Bogard; Harry Y Domen; Alan R Katz; Henry Y Higa; David M Sasaki
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

7.  Epidemiology of leptospirosis in New Caledonia (South Pacific): a one-year survey.

Authors:  A Perrocheau; P Perolat
Journal:  Eur J Epidemiol       Date:  1997-02       Impact factor: 8.082

8.  An observational study to detect leptospirosis in Mumbai, India, 2000.

Authors:  S Karande; M Bhatt; A Kelkar; M Kulkarni; A De; A Varaiya
Journal:  Arch Dis Child       Date:  2003-12       Impact factor: 3.791

9.  Studying risk factors associated with human leptospirosis.

Authors:  Ramachandra Kamath; Subhashisa Swain; Sanjay Pattanshetty; N Sreekumaran Nair
Journal:  J Glob Infect Dis       Date:  2014-01

10.  Leptospirosis: skin wounds and control strategies, Thailand, 1999.

Authors:  Phran Phraisuwan; Ellen A Spotts Whitney; Piyanit Tharmaphornpilas; Suriya Guharat; Samart Thongkamsamut; Suphaporn Aresagig; Jayteeya Liangphongphanthu; Kanlayanee Junthima; Apirat Sokampang; David A Ashford
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.